Renaissance Technologies
BLFS

Renaissance Technologies’s BioLife Solutions BLFS Stock Holding History

Renaissance Technologies’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207,128
Closed -$3.95M – 3215
2026
Q1 		$3.95M Sell
207,128
-17,572
-8% -$388K 0.01% 1505
2025
Q4 		$5.43M Buy
224,700
+32,500
+17% +$850K 0.01% 1253
2025
Q3 		$4.9M Sell
192,200
-113,900
-37% -$2.7M 0.01% 1509
2025
Q2 		$6.59M Buy
306,100
+259,100
+551% +$5.84M 0.01% 1338
2025
Q1 		$1.07M Buy
47,000
+25,900
+123% +$682K ﹤0.01% 2382
2024
Q4 		$548K Sell
21,100
-33,280
-61% -$828K ﹤0.01% 2799
2024
Q3 		$1.36M Buy
54,380
+25,680
+89% +$607K ﹤0.01% 2259
2024
Q2 		$615K Buy
+28,700
New +$557K ﹤0.01% 2598
2023
Q2 		– Sell
-34,300
Closed -$746K – 3920
2023
Q1 		$746K Buy
+34,300
New +$771K ﹤0.01% 2658
2022
Q3 		– Sell
-179,200
Closed -$2.48M – 4034
2022
Q2 		$2.48M Buy
179,200
+151,600
+549% +$2.22M ﹤0.01% 2035
2022
Q1 		$627K Buy
+27,600
New +$727K ﹤0.01% 3035
2021
Q4 		– Sell
-66,600
Closed -$2.82M – 3902
2021
Q3 		$2.82M Buy
+66,600
New +$3.21M ﹤0.01% 1838
2021
Q2 		– Sell
-82,400
Closed -$2.97M – 3462
2021
Q1 		$2.97M Buy
+82,400
New +$3.26M ﹤0.01% 1974
2020
Q2 		– Sell
-39,200
Closed -$372K – 3443
2020
Q1 		$372K Buy
39,200
+8,946
+30% +$123K ﹤0.01% 2893
2019
Q4 		$490K Buy
30,254
+14,954
+98% +$243K ﹤0.01% 2911
2019
Q3 		$254K Sell
15,300
-105,300
-87% -$1.98M ﹤0.01% 3081
2019
Q2 		$2.04M Sell
120,600
-189,300
-61% -$3.3M ﹤0.01% 2316
2019
Q1 		$5.54M Sell
309,900
-133,600
-30% -$2.13M 0.01% 1741
2018
Q4 		$5.33M Buy
443,500
+15,600
+4% +$186K 0.01% 1686
2018
Q3 		$7.49M Buy
427,900
+221,000
+107% +$4.37M 0.01% 1543
2018
Q2 		$2.36M Buy
206,900
+179,100
+644% +$1.63M ﹤0.01% 2181
2018
Q1 		$143K Sell
27,800
-9,799
-26% -$53K ﹤0.01% 3226
2017
Q4 		$226K Sell
37,599
-49,301
-57% -$284K ﹤0.01% 3099
2017
Q3 		$496K Buy
+86,900
New +$360K ﹤0.01% 2787

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies's BLFS Position: Q2 2026 in Review

Renaissance Technologies sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 207,128 shares — an estimated $3.95M sold.

Renaissance Technologies first reported a position in BLFS in Q3 2017 and held it in 24 quarters. The position peaked at $7.49M in Q3 2018. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Renaissance Technologies reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 207,128 BioLife Solutions shares in Q2 2026, an estimated $3.95M.
  • Renaissance Technologies first reported a position in BioLife Solutions in Q3 2017 and held it in 24 quarters.
  • Renaissance Technologies's BioLife Solutions position peaked at $7.49M in Q3 2018.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.